Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles

Antiviral Research

Volumn 143, Issue , 2017, Pages 230-236

  Albulescu, Irina C ^a   Kovacikova, Kristina ^a   Tas, Ali ^a   Snijder, Eric J ^a   van Hemert, Martijn J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SURAMIN; VIRUS RNA; MYCOPHENOLIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG PROTEIN BINDING; EC50; HOST CELL; LIMIT OF DETECTION; NONHUMAN; PRIORITY JOURNAL; PROGENY; RNA ANALYSIS; RNA SYNTHESIS; SCINTILLATION COUNTING; SELECTIVITY INDEX; VERO CELL LINE; VIRAL PLAQUE ASSAY; VIRUS ATTACHMENT; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; ZIKA FEVER; ZIKA VIRUS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHLOROCEBUS AETHIOPS; DNA REPLICATION; DRUG EFFECTS; FLAVIVIRUS; GLYCOSYLATION; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; TIME FACTOR; VIRION; VIROLOGY; VIRUS ENTRY;

ANIMALS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; DNA REPLICATION; FLAVIVIRUS; GLYCOSYLATION; MYCOPHENOLIC ACID; RNA, VIRAL; SURAMIN; TIME FACTORS; VERO CELLS; VIRION; VIRUS ATTACHMENT; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85018327114     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2017.04.016     Document Type: Article

References (37)

1. Adcock, R.S., Chu, Y.K., Golden, J.E., Chung, D.H., Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Antivir. Res. 138 (2017), 47–56.
2. Albulescu, I.C., van Hoolwerff, M., Wolters, L.A., Bottaro, E., Nastruzzi, C., Yang, S.C., Tsay, S.C., Hwu, J.R., Snijder, E.J., van Hemert, M.J., Suramin inhibits chikungunya virus replication through multiple mechanisms. Antivir. Res. 121 (2015), 39–46.
3. Baghdiguian, S., Boudier, J.L., Boudier, J.A., Fantini, J., Intracellular localisation of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography. Eur. J. Cancer 32A (1996), 525–532.
4. Barrows, N.J., Campos, R.K., Powell, S.T., Prasanth, K.R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Munoz, G., McGrath, E.L., Urrabaz-Garza, R., Gao, J., Wu, P., Menon, R., Saade, G., Fernandez-Salas, I., Rossi, S.L., Vasilakis, N., Routh, A., Bradrick, S.S., Garcia-Blanco, M.A., A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe 20 (2016), 259–270.
5. Basavannacharya, C., Vasudevan, S.G., Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format. Biochem. Biophys. Res. Commun. 453 (2014), 539–544.
6. Berthet, N., Nakoune, E., Kamgang, B., Selekon, B., Descorps-Declere, S., Gessain, A., Manuguerra, J.C., Kazanji, M., Molecular characterization of three Zika flaviviruses obtained from sylvatic mosquitoes in the Central African Republic. Vector Borne Zoonotic Dis. 14 (2014), 862–865.
7. Chandra, P., Vogel, A., Gerber, T., Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS. Cancer Res. 45 (1985), 4677s–4684s.
8. Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J., Marks, R.M., Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3 (1997), 866–871.
9. Cheng, F., Murray, J.L., Rubin, D.H., Drug repurposing: new treatments for Zika virus infection?. Trends Mol. Med. 22 (2016), 919–921.
10. Coffey, R.J. Jr., Leof, E.B., Shipley, G.D., Moses, H.L., Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell Physiol. 132 (1987), 143–148.
11. Dallmeier, K., Neyts, J., Zika and other emerging viruses: aiming at the right target. Cell Host Microbe 20 (2016), 420–422.
12. De Clercq, E., Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Lett. 8 (1979), 9–22.
13. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
14. Garcia-Blanco, M.A., Vasudevan, S.G., Bradrick, S.S., Nicchitta, C., Flavivirus RNA transactions from viral entry to genome replication. Antivir. Res. 134 (2016), 244–249.
15. Henss, L., Beck, S., Weidner, T., Biedenkopf, N., Sliva, K., Weber, C., Becker, S., Schnierle, B.S., Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virol. J., 13, 2016, 149.
16. Ho, Y.J., Wang, Y.M., Lu, J.W., Wu, T.Y., Lin, L.I., Kuo, S.C., Lin, C.C., Suramin inhibits chikungunya virus entry and transmission. PLoS One, 10, 2015, e0133511.
17. Kim, S.Y., Zhao, J., Liu, X., Fraser, K., Lin, L., Zhang, X., Zhang, F., Dordick, J.S., Linhardt, R.J., Interaction of Zika virus envelope protein with glycosaminoglycans. Biochemistry 56 (2017), 1151–1162.
18. Kuno, G., Chang, G.J., Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch. Virol. 152 (2007), 687–696.
19. Kuo, S.C., Wang, Y.M., Ho, Y.J., Chang, T.Y., Lai, Z.Z., Tsui, P.Y., Wu, T.Y., Lin, C.C., Suramin treatment reduces chikungunya pathogenesis in mice. Antivir. Res. 134 (2016), 89–96.
20. Li, J., Bhuvanakantham, R., Howe, J., Ng, M.L., The glycosylation site in the envelope protein of West Nile virus (Sarafend) plays an important role in replication and maturation processes. J. Gen. Virol. 87 (2006), 613–622.
21. Liu, S., DeLalio, L.J., Isakson, B.E., Wang, T.T., AXL-mediated productive infection of human endothelial cells by Zika virus. Circ. Res. 119 (2016), 1183–1189.
22. Mastrangelo, E., Pezzullo, M., Tarantino, D., Petazzi, R., Germani, F., Kramer, D., Robel, I., Rohayem, J., Bolognesi, M., Milani, M., Structure-based inhibition of Norovirus RNA-dependent RNA polymerases. J. Mol. Biol. 419 (2012), 198–210.
23. Meertens, L., Labeau, A., Dejarnac, O., Cipriani, S., Sinigaglia, L., Bonnet-Madin, L., Le Charpentier, T., Hafirassou, M.L., Zamborlini, A., Cao-Lormeau, V.M., Coulpier, M., Misse, D., Jouvenet, N., Tabibiazar, R., Gressens, P., Schwartz, O., Amara, A., Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep. 18 (2017), 324–333.
24. Miner, J.J., Diamond, M.S., Zika virus pathogenesis and tissue tropism. Cell Host Microbe 21 (2017), 134–142.
25. Mossenta, M., Marchese, S., Poggianella, M., Slon Campos, J.L., Burrone, O.R., Role of N-glycosylation on Zika virus E protein secretion, viral assembly and infectivity. Biochem. Biophys. Res. Commun., 2017 pii: S0006-291X(17)30022-0.
26. Mukherjee, S., Hanson, A.M., Shadrick, W.R., Ndjomou, J., Sweeney, N.L., Hernandez, J.J., Bartczak, D., Li, K., Frankowski, K.J., Heck, J.A., Arnold, L.A., Schoenen, F.J., Frick, D.N., Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays. Nucleic Acids Res. 40 (2012), 8607–8621.
27. Nishimura, Y., McLaughlin, N.P., Pan, J., Goldstein, S., Hafenstein, S., Shimizu, H., Winkler, J.D., Bergelson, J.M., The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate. PLoS Pathog., 11, 2015, e1005184.
28. Ren, P., Zou, G., Bailly, B., Xu, S., Zeng, M., Chen, X., Shen, L., Zhang, Y., Guillon, P., Arenzana-Seisdedos, F., Buchy, P., Li, J., von Itzstein, M., Li, Q., Altmeyer, R., The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo. Emerg. Microbes Infect., 3, 2014, e62.
29. Richard, A.S., Shim, B.S., Kwon, Y.C., Zhang, R., Otsuka, Y., Schmitt, K., Berri, F., Diamond, M.S., Choe, H., AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses. Proc. Natl. Acad. Sci. U. S. A. 114 (2017), 2024–2029.
30. Scholte, F.E., Tas, A., Martina, B.E., Cordioli, P., Narayanan, K., Makino, S., Snijder, E.J., van Hemert, M.J., Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates. PLoS One, 8, 2013, e71047.
31. Scholte, F.E., Tas, A., Albulescu, I.C., Žusinaite, E., Merits, A., Snijder, E.J., van Hemert, M.J., Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication. J. Virol. 89 (2015), 4457–4469.
32. Tabata, T., Petitt, M., Puerta-Guardo, H., Michlmayr, D., Wang, C., Fang-Hoover, J., Harris, E., Pereira, L., Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe 20 (2016), 155–166.
33. Tarantino, D., Pezzullo, M., Mastrangelo, E., Croci, R., Rohayem, J., Robel, I., Bolognesi, M., Milani, M., Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase. Antivir. Res. 102 (2014), 23–28.
34. Van Boheemen, S., Tas, A., Anvar, S.Y., van Grootveld, R., Albulescu, I.C., Bauer, M.P., Feltkamp, M.C., Bredenbeek, P.J., van Hemert, M.J., Quasispecies composition and evolution of a typical Zika virus clinical isolate from Suriname. Sci. Rep., 2017 (in press).
35. Waltenberger, J., Mayr, U., Frank, H., Hombach, V., Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J. Mol. Cell Cardiol. 28 (1996), 1523–1529.
36. Wu, Z.S., Liu, C.F., Fu, B., Chou, R.H., Yu, C., Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activity. Biochem. Biophys. Res. Commun. 477 (2016), 861–867.
37. Xu, M., Lee, E.M., Wen, Z., Cheng, Y., Huang, W.K., Qian, X., Tcw, J., Kouznetsova, J., Ogden, S.C., Hammack, C., Jacob, F., Nguyen, H.N., Itkin, M., Hanna, C., Shinn, P., Allen, C., Michael, S.G., Simeonov, A., Huang, W., Christian, K.M., Goate, A., Brennand, K.J., Huang, R., Xia, M., Ming, G.L., Zheng, W., Song, H., Tang, H., Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat. Med. 22 (2016), 1101–1107.